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Purpose: To evaluate the impact of high body mass index (BMI) on outcomes fol-
lowing robotic laparoendoscopic single-site surgery (R-LESS) robotic-assisted lap-
aroscopic partial nephrectomy (RPN). Materials and Methods: Data from 83 Ko-
rean patients who had undergone robotic partial nephrectomy from 2006 to 2014 
were retrospectively analyzed. The subjects were stratified into two groups accord-
ing to WHO definitions for the Asian population, consisting of 56 normal range 
(BMI=18.5‒24.99 kg/m2) and 27 obese (≥25 kg/m2) patients. Outcome measure-
ments included Trifecta achievement and the perioperative and postoperative com-
parison between high and normal BMI series. The measurements were estimated 
and analyzed with SPSS version 17. Results: Tumor’s complexity characteristics 
(R.E.N.A.L. score, tumor size) of both groups were similar. No significant differ-
ences existed between the two groups with regard to operative time (p=0.27), warm 
ischemia time (p=0.35) estimated blood loss (p=0.42), transfusion rate (p=0.48) re-
nal function following up for 1 year, positive margins (p=0.24) and postoperative 
complication rate (p=0.34). Trifecta was achieved in 5 (18.5%) obese and 19 
(33.9%) normal weight patients, respectively (p=0.14). In multivariable analysis, 
only tumor size was significantly correlated with the possibility of Trifecta accom-
plishment. Conclusion: Our findings suggest that R-LESS RPN can be effectively 
and safely performed in patients with increased BMI, since Trifecta rate, and peri-
operative and postoperative outcomes are not significantly different in comparison 
to normal weight subjects.
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INTRODUCTION
The development of imaging techniques has increased the detection rates of small-
er size and lower stage renal cell carcinomas (RCC).1 Therefore, renal surgery is 
steadily evolving towards nephron-sparing minimally invasive procedures.2 Ro-
botic-assisted laparoscopic partial nephrectomy (RPN) is a minimally invasive 
technique associated with good functional and oncologic outcomes in the treat-
ment of small and medium size renal masses.3 RPN can be performed by either the 
multi-port (conventional) approach or by the laparoendoscopic single-site tech-
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tion of warm ischemia time (WIT) less than 20 minutes, 
negative surgical margins and no surgical complications as 
a denotation of oncological and surgical safety, respective-
ly.11 Postoperative complications were recorded for a dura-
tion of three months after surgery, according to Clavien-
Dindo classification system.12
Preoperative clinical and demographic characteristics 
[age, gender, BMI, tumor size, physical status classification 
of American Society of Anesthesiologists (ASA), estimated 
glomerular filtration rate (eGFR), R.E.N.A.L. score] were 
retrospectively analyzed in order to identify possible signifi-
cant differences between the baseline characteristics of these 
groups. R.E.N.A.L. scoring system was used to account for 
tumor complexity.13 Perioperative and postoperative out-
comes and surgical complications were also analyzed and 
compared between the groups [operative time, estimated 
blood loss (EBL), WIT, postoperative eGFR, number of pa-
tients with positive surgical margins, days of hospitalization 
‒length of stay, days of drain maintenance, number of pa-
tients who underwent conversion to radical nephrectomy 
surgery]. In order to estimate the impact of high BMI on the 
functional outcome, we counted and compared the eGFR, in 
addition to eGFR percentage change, between the groups. 
eGFR percentage change was defined as the percentage of 
difference between preoperative and postoperative eGFR in 
each group (eGFR change: 1-postoperative eGFR/preopera-
tive eGFR×%). Patient’s e-GFR was determined using the 
Modification of Diet in Renal Disease Formula.14 The post-
operative renal function was evaluated in a intermediate 
term follow up of one year.
Surgical technique
The R-LESS PN procedure was performed according to our 
previously described approach.15 A homemade single-port 
device was used in all cases. Laparoscopic ultrasound was 
used intraoperatively in all cases, in order to identify tumor 
depth and margin. The surgical steps included tumor identi-
fication, temporary occlusion of the renal vessels, tumor ex-
cision and renorrhaphy using the sliding clip technique.
Statistical analysis
Differences between the two groups were compared by using 
either the Mann-Whitney test for continuous variables or the 
chi-square test for 2×2 contingency or larger tables, respec-
tively. Counts of frequencies were expressed as percentages 
and continuous data were presented as the median and inter-
quartile range. A multivariate binary logistic regression anal-
nique (R-LESS), with the latter being considered to achieve 
superior cosmetic outcome than multi-port technique.4
However, concerns remain regarding the safety and effica-
cy of RPN in patients with high body mass index (BMI). 
Obesity is one of the known risk factors for developing RCC, 
thus many patients who suffer from renal tumors and are 
treated with RPN are expected to have a high BMI.5 Addi-
tionally, as the prevalence of obesity continues to rise, more 
obese patients are  possible candidates of having minimally 
invasive procedures. Technical difficulties, secondary to 
body habitus and increased perirenal fat, may be encountered 
during surgery.6 The correlation between BMI and periopera-
tive and postoperative outcomes after RPN is controversial.7-9 
In order to determine the influence of high BMI on the 
outcomes of patients who have undergone R-LESS partial 
nephrectomy (PN), we performed a retrospective analysis 
of our R-LESS RPN series, focusing on the impact of high 
BMI in regard to perioperative and postoperative outcomes, 
and Trifecta accomplishment. To our knowledge, no study 
has so far been carried out regarding the influence of BMI 
on the operative outcomes of R-LESS PN, as well as the ef-
fect of high BMI in terms of Trifecta achievement.
MATERIALS AND METHODS
Patient’s selection and outcome measurements
Data of 220 Korean patients with renal tumor, who had un-
dergone multi-port and LESS robotic partial nephrectomy 
by a single surgeon in a tertiary institute, between October 
2006 and March 2014, was obtained and retrospectively 
analyzed from our prospectively maintained Institutional 
Review Board approved database. One hundred-seventeen 
patients who underwent conventional (multi-port) RPN were 
excluded from the analysis.
BMI was defined as the weight in kilograms divided by 
the square of the height in meters. The subjects were catego-
rized into two groups according to WHO definitions for the 
Asian population, consisting of 56 normal range (BMI= 
18.5‒24.99 kg/m2) and 27 high BMI (≥25 kg/m2) patients 
who underwent R-LESS PN.10 The patients were sequen-
tially enrolled to either conventional RPN or R-LESS PN 
without any selection criteria. 
Outcome measurements were Trifecta achievement, as 
well as the perioperative and postoperative outcomes. Based 
on our previous published article regarding Trifecta accom-
plishment, we defined Trifecta achievement as a combina-
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ences between the groups regarding to postoperative renal 
function, as estimated by the measurement of eGFR and the 
eGFR percentage change at postoperative day 1, 1 week, 1 
month, 3 months, 6 months, and 1 year after surgery (p=0.87 
and 0.53, 0.78 and 0.98, 0.72 and 0.45, 0.61 and 0.42, 0.80 
and 0.97, 0.84 and 0.29, respectively) (Fig. 1). In two pa-
tients with normal BMI, a conversion to radical nephrecto-
my was performed, due to severe perioperative hemorrhage 
or difficulties in assessing the tumor extension with the ro-
botic arms (p=0.32). Three patients with high BMI required 
endoscopically ureteral stent placement due to urinary leak-
age (2 patients) and renal artery embolization due to hemor-
rhage (1 patient). Seven patients (12.5%) in normal BMI 
group and two (7.4%) in high BMI group required blood 
transfusion (p=0.48). Trifecta was achieved in 19 normal 
weight patients (33.9%) and 5 patients (18.5%) of high BMI 
group (p=0.14).
Multiple logistic regression analysis, detected that tumor 
size was the only variable which could predict the failure of 
achieving Trifecta (odds ratio: 1.964, p=0.013) (Table 3).
DISCUSSION
With the rising incidence of obesity worldwide and the in-
creasing use of robot in the treatment of renal tumors, nu-
merous overweight patients are expected to undergo RPN. 
ysis was also performed, so as to determine the most impor-
tant explanatory variables for Trifecta accomplishment. 
For all statistical analyses, a two-sided p value <0.05 was 
considered statistically significant. All analyses were per-
formed using SPSS version 17 statistical package (SPSS 
Inc., Chicago, IL, USA).
RESULTS
 
There were no statistically significant differences in the base-
line characteristics between the two groups regarding age 
(p=0.88), ASA score (p=0.24), tumor size (p=0.62), tumor 
side (p=0.77), R.E.N.A.L. score (p=0.84) and T stage (p= 
0.62) of the tumor. Despite the fact that increased percentage 
of malignant tumors was observed in high BMI subjects, this 
was not statistical significant (p=0.20). The patients’ clinical 
and demographic characteristics are summarized in Table 1.
Table 2 presents the perioperative and postoperative data 
of both groups. With regard to perioperative outcomes, we 
did not detect any statistical significant differences between 
the two groups regarding operative time, WIT, EBL, rates 
of patients with positive surgical margins (2.2% vs. 8.0% 
for normal and high BMI patients, respectively), surgical 
complications, days of hospitalization and drain preserva-
tion (p=0.25, 0.35, 0.42, 0.24, 0.34, 0.80, 0.62, respective-
ly). We did not also find any statistically significant differ-
Table 1. Clinical and Demographic Characteristics of Patients*
Characteristic     Normal BMI (18‒25 kg/m2)  High BMI (>25 kg/m2) p value
Number 56 27
Sex (n) F (23)/M (33) F (8)/M (19)     0.31
Age (yrs) 52.5 (44‒61) 51 (44‒61)     0.88
BMI (kg/m2)       22.5 (21.1‒23.7)    27.0 (25.3‒28.3)     <0.001
Side (n) L (23)/R (33) L (12)/R (15)     0.77
ASA score (%)     0.24
    1 80.0 74.1     
    2 14.5 25.9
    3   5.5   0.0
Tumor size (cm)      2.7 (1.75‒4.0)    3.0 (2.0‒4.7)     0.62
R.E.N.A.L. score 7 (6‒9) 7 (6‒9)     0.84
Malignancy (%) 82.1 92.6     0.20
pT stage (%)     0.62
    T1a 78.3 68.0
    T1b 19.6 28.0
    T2   2.2   4.0
    T3   0.0   0.0
n, number; F, female; M, male; BMI, body mass index; L, left; R, right; ASA, physical status classification of American Society of Anesthesiologists.
*Continuous variables are expressed as median and interquartile range. 
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served lower Trifecta rates in the R-LESS PN group than 
previously published studies.19 This could probably be ex-
plained by the stringent definition of Trifecta that we have 
used in our analysis (WIT <20 min, no complications, nega-
tive margins). Moreover, in a previous study from our group, 
Trifecta achievement rates were found to be lower in the R-
LESS PN group compared to the conventional approach.11
Analyzing our data, we detected that obese patients were 
more likely to be males and having malignant tumors, al-
Additionally, the acceptance of R-LESS technique as a pro-
cedure with better cosmetic outcome and less postoperative 
pain than the conventional approach will probably result in 
an increased appliance of R-LESS PN in overweight pa-
tients.4 Therefore, studies regarding the safety and efficacy 
of R-LESS RPN in individuals with high BMI are required. 
According to many authors including us, Trifecta achieve-
ment (i.e., the triple goals of negative surgical margins, func-
tional preservation and complication free recovery) follow-
ing robotic partial nephrectomy remains the surgeon’s top 
priority in the treatment of a patient having a malignant tu-
mor.16-18 In the present study, therefore, we analyzed our data 
with regard to Trifecta accomplishment. To our best knowl-
edge, the current analysis represents the first analysis com-
paring Trifecta achievement in obese versus normal BMI 
patients in R-LESS RPN procedure.
The present study demonstrates that R-LESS PN is effi-
cient and safe in subjects with high BMI, since no signifi-
cant difference was detected regarding complication rate, 
transfusion rate, operative time, WIT, functional outcome 
and oncological safety compared to normal BMI patients. 
Moreover, the Trifecta rate was similar in both groups, sug-
gesting that RPN can be safely performed in patients with 
increased BMI.
Although the rates of Trifecta accomplishment were simi-
lar between patients with high and normal BMI, we ob-
Table 2. Perioperative and Postoperative Outcomes of Both Groups* 
Variable Normal BMI (m±SD)  High BMI (m±SD) p value
Operative time (min)   190 (148‒220)   203 (176‒247) 0.27
WIT (min)     25 (16‒31)     27 (21‒36) 0.35
EBL (mL)   200 (50‒500)   300 (50‒500) 0.42
BT (n, %)       7 (12.5)       2 (7.4) 0.48
PSM (%)       1 (2.2)       2 (8.0) 0.24
Clavien III‒IV complications  (%)†       1 (3.6)       3 (11.1) 0.34
Conversion to RN (n, %)       2 (3.6)       0 (0.0) 0.32
Drain (d)    2.0 (2‒3)    2.5 (2‒3) 0.62
LOS (d)    4.0 (3‒5)    4.0 (3‒5) 0.80
Trifecta (n) (%)     19 (33.9)       5 (18.5) 0.14
Preop. eGFR  85.1 (78.1‒94.0)  85.4 (75.1‒94.2) 0.91
1st day eGFR  66.0 (58.7‒78.6)  67.4 (51.1‒84.4) 0.87
1st day eGFR change (%) -22.5 (-29 to -7) -21.8 (-39 to -7) 0.53
1st yr eGFR  81.0 (67.3‒95.3)  78.2 (69.2‒90.9) 0.84
1st yr eGFR change (%)   -2.7 (-17 to -7)   -8.2 (-17 to -7) 0.29
Follow-up (months)     47 (40‒52)     47 (37‒51) 0.42
BMI, body mass index; EBL, estimated blood loss; BT, patients that required blood transfusion; WIT, warm ischemia time; PSM, positive surgical margins; 
RN, radical nephrectomy; LOS, length of stay; eGFR, estimated glomerular filtration rate (mL/min/1.73 m2); eGFR change (%), 1-(postoperative eGFR/preop-
erative eGFR)×%.
*Continuous variables are expressed as median and interquartile range. 
†Three patients with high BMI required endoscopically ureteral stent placement due to urinary leakage (2) and renal artery embolization due to hemor-
rhage (1). 
Fig. 1. eGFR (mL/min/1.73 m2) trends during a period of 12 months after 
R-LESS PN in patients with normal BMI and high BMI, respectively. eGFR, 
estimated glomerular filtration rate (mL/min/1.73 m2); BMI, body mass in-
dex; R-LESS, robotic laparoendoscopic single-site surgery; PN, partial ne-
phrectomy.
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the authors concluded that RPN can be safely performed in 
high-volume centers. 
Recently, Aboumarzouk, et al.22 meta-analyzed the pub-
lished data of laparoscopic partial nephrectomy in obese pa-
tients and observed comparable outcomes between obese 
and non-obese patients, despite the fact that laparoscopic par-
tial nephrectomy constitutes a more challenging  procedure.
In all of the above studies, the renal function evaluated by 
eGFR was not influenced by the increased BMI. This is also 
supported by our analysis, in which we did not detect any 
significant difference in the postoperative renal function of 
the groups, although eGFR and eGFR percentage changes 
were measured in a medium term follow up of 12 months.
There are three limitations in our study. First, this study is 
a retrospective nature, although data were retrieved from a 
prospectively maintained institutional database. Second, all 
the procedures were performed by a very experienced ro-
botic surgeon specialized in minimally invasive PN proce-
dures, who had reached the learning curve for both tech-
niques. Therefore, the current findings might not apply to 
other populations in different hospital settings. Third, the 
classification of obesity in Asians is different compared to 
the European and American population, therefore, the find-
ings of our study might not be similar in other regions. 
However, the findings in the current literature concur with 
most of those in the present study.
In conclusion, we do not necessarily advocate robotic as-
sistance for all obese patients undergoing partial nephrecto-
my, nevertheless, our findings suggest that R-LESS partial 
nephrectomy can be effectively and safely performed to 
overweight patients, since major parameters, such as post 
surgery renal function (eGFR), surgical complications and 
oncological safety are not significantly different in compar-
ison to normal weight individuals.
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though this was not statistically significant. This is logical 
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Since the perioperative and postoperative comparison 
could be influenced by the different anatomic and topo-
graphic characteristics of the treated tumor, we also estimat-
ed and compared tumor complexity in both groups by 
R.E.N.A.L. score.13 R.E.N.A.L. score and tumor size were 
not significantly different between high BMI and normal 
weight patients. Therefore, we believe that a tumor’s com-
plexity does not constitute a confusing factor in our results, 
while surgical confounders were minimized using the out-
comes of a single surgeon. 
Our results are in agreement with the study of Isac, et al.7 
The authors analyzed the data of 250 patients who had un-
dergone conventional RPN and also found not significant 
difference between the groups in terms of operation dura-
tion, WIT, transfusion rate and postoperative complication 
rate. They also reported significant difference in EBL only 
in patients with highly increased BMI (>40), whereas  simi-
lar transfusion rate between the groups. In the present study, 
blood loss volume was higher in overweight patients, how-
ever, this was not statistically significant. Moreover, the 
transfusion rate was comparable between the high and nor-
mal BMI patients (7.4% and 12.5%, respectively).
Naeem, et al.,8 in their study of 97 patients, found that the 
obese patients had a higher EBL and a trend toward longer 
operative time and WIT, which did not achieve statistical 
significance. In our series, we also observed that WIT was 
greater in high BMI group (25 minutes vs. 27 minutes), but 
the difference was not statistically significant.
In contrast, Kiziloz, et al.9 found that increasing BMI is 
significantly associated with longer operative time, length 
of hospital stay and increased EBL, whereas there are no 
correlations between BMI, WIT, change in eGFR, and peri-
operative and postoperative complications. Nevertheless, 
Table 3. Binary Logistic Regression Analysis of Trifecta Accomplishment
Variable OR 95% CI  p value
High BMI 3.138 0.82‒11.8 0.093
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Operative time 1.005 0.99‒1.01 0.165
Tumor size 1.964 1.15‒3.34 0.013
R.E.N.A.L. score 1.293 0.89‒1.87 0.178
OR, odds ratio; CI, confidence interval; BMI, body mass index.
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